Keyphrases
Rift Valley Fever Virus
100%
Virus
85%
Ebola Virus
75%
Nipah Virus
74%
MP-12
44%
Virus Infection
39%
Filovirus
30%
Henipavirus
28%
Ebola Virus Infection
28%
Recombinant
24%
Hemorrhagic Fever
23%
Mouse Model
23%
COVID-19
23%
Antiviral Activity
22%
Favipiravir
22%
Nipah Virus Infection
21%
MP-12 Vaccine
21%
Phlebovirus
20%
Rift Valley Fever
19%
Lethal Challenge
17%
Hendra Virus
17%
Inflammatory Response
17%
Africa
17%
Attenuation
16%
Bunyavirus
15%
Paramyxovirus
15%
Rift Valley Fever Vaccine
15%
VP35
14%
Vaccine Candidate
14%
Ebola Virus Disease
14%
Matrix Protein
14%
Polyphenylene Carboxymethylene
14%
Arenavirus
14%
Live Attenuated
14%
TRIM6
14%
Ruminants
13%
Vaccine Strain
13%
Marburg Virus
13%
Hamster Model
13%
Ebola
13%
Virus Replication
12%
Encephalitis
12%
Tailspike Protein
12%
Phage
12%
T-705
12%
Entry Inhibitor
12%
Viral
12%
Viral Infection
12%
Viral Replication
12%
S Segment
12%
Immunology and Microbiology
Rift Valley Fever Virus
84%
Viral Disease
70%
Ebola Virus
68%
Nipah Virus
65%
Henipavirus
38%
Rift Valley Fever
34%
Phlebovirus
29%
interferon
29%
Wild Type
29%
Glycoprotein
28%
Filovirus
28%
Viral Replication
27%
Mouse Model
23%
Hemorrhagic Fever
22%
Paramyxoviridae
22%
Bunyaviridae
20%
Severe Acute Respiratory Syndrome Coronavirus 2
18%
Inflammation Response
18%
Hendra Virus
16%
Antiviral Activity
15%
Encephalitis
14%
Knockout Mouse
13%
RNA Virus
13%
Innate Immune System
12%
Adenoviridae
12%
Bacteriophage
12%
Viral Entry
12%
Cytokine Response
11%
Marburgvirus
11%
Matrix Protein
11%
Neutralization
11%
Immunity
10%
Virus
10%
Virus Strain
10%
Ebola Vaccine
9%
Immune Response
9%
West Nile Virus
9%
Virus-Like Particle
9%
Genetic Variability
9%
Neural Stem Cell
9%
Virus Nucleocapsid
9%
Uukuniemi Virus
8%
Immunogenicity
8%
Chemokine
8%
Cell Line
8%
Viral Transcription
8%
Sandfly Fever Sicilian Virus
8%
Antiviral Immunity
8%
Amino Terminal Sequence
8%
Virus Genome
8%